Haemonetics (HAE) Acquisitions (2010 - 2026)

Haemonetics' Acquisitions history runs 10 years deep, the most recent figure standing at $60.2 million for Q1 2026.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $60.2 million in Q1 2026; TTM through Mar 2026 was $60.2 million, a 60.12% decrease from a year earlier, with the FY2026 full-year figure at $60.2 million, down 60.12% from the prior year.
• Acquisitions advanced to $60.2 million in Q1 2026 per HAE's latest filing, from $1.8 million in the prior quarter.
• Across five years, Acquisitions topped out at $243.9 million in Q4 2023 and bottomed at $1.8 million in Q3 2024.
• The 4-year median for Acquisitions is $104.7 million (2024), against an average of $116.5 million.
• Biggest YoY gain for Acquisitions was 14.0% in 2022; the steepest drop was 14.0% in 2022.
• Year by year, Acquisitions stood at $2.8 million in 2022, then soared by 8456.21% to $243.9 million in 2023, then plunged by 99.28% to $1.8 million in 2024, then soared by 3329.06% to $60.2 million in 2026.
• Per Business Quant, the three latest HAE Acquisitions figures stand at $60.2 million (Q1 2026), $1.8 million (Q3 2024), and $149.2 million (Q2 2024).